Recurrent urinary tract infections in older adults: A systematic review of current challenges and emerging therapeutic strategies
By: Junmei Lv and Ajaz Ahmad Waza
References
- C. L. Richards, Urinary tract infections in the frail elderly: Issues for diagnosis, treatment and prevention, Int. Urol. Nephrol. 36(3) (2004) 457–463; https://doi.org/10.1007/s11255-004-4870-6
- G. Zeng, W. Zhu, W. Lam and A. Bayramgil, Treatment of urinary tract infections in the old and fragile, World J. Urol. 38(11) (2020) 2709–2720; https://doi.org/10.1007/s00345-020-03159-2
- A. Artero, I. Lopez-Cruz, J. A. Aguilera, L. Piles, S. Artero, J. M. Eiros, J. Alberola and M. Madrazo, Recurrent urinary tract infections in older adults requiring hospitalization in an internal medicine ward, Microorganisms 12(11) (2024) Article ID 2114 (9 pages); https://doi.org/10.3390/microorganisms12112114
- R. D. Klein and S. J. Hultgren, Urinary tract infections: Microbial pathogenesis, host-pathogen interactions and new treatment strategies, Nat. Rev. Microbiol. 18(4) (2020) 211–226; https://doi.org/10.1038/s41579-020-0324-0
- M. Al Qahtani, M. E. D. M. Naghib, A. M. M. Alshamrani, A. M. Al Mazroua, A. S. A. Alayyaf, S. B. Ofisan and S. M. Kamal, The incidence, clinical features and outcome of urinary tract infections in geriatric patients: A prospective longitudinal study, IJID Regions 13 (2024) Article ID 100469 (8 pages);https://doi.org/10.1016/j.ijregi.2024.100469 https://doi.org/10.1016/j.ijregi.2024.100469
- M. Medina and E. Castillo-Pino, An introduction to the epidemiology and burden of urinary tract infections, Ther. Adv. Urol. 11 (2019) Article ID 1756287219832172 (5 pages); https://doi.org/10.1177/1756287219832172
- J. T. Wei, C. A. Dauw and C. N. Brodsky, Lower urinary tract symptoms in men: A review, JAMA 334(9) (2025) 809–821; https://doi.org/10.1001/jama.2025.7045
- N. W. Cortes-Penfield, B. W. Trautner and R. L. P. Jump, Urinary tract infection and asymptomatic bacteriuria in older adults, Infect. Dis. Clin. North Am. 31(4) (2017) 673–688; https://doi.org/10.1016/j.idc.2017.07.002
- J. A. Stocki, R. C. Fleck, I. B. Nguyen, R. Walde, H. L. T. Mobley and A. E. Shea, Asymptomatic bacteriuria screening for developing countries using a modified water quality test kit, Appl. Environ. Microbiol. 90(11) (2024) Article ID e0156724 (16 pages); https://doi.org/10.1128/aem.01567-24
- J. F. Timsit, L. Ling, E. de Montmollin, H. Bracht, A. Conway-Morris, L. De Bus, M. Falcone, P. N. A. Harris, F. R. Machado, J. A. Paiva, D. L. Paterson, G. Poulakou, J. A. Roberts, C. Roger, A. F. Shorr, A. Tabah and J. Lipman, Antibiotic therapy for severe bacterial infections, Intensive Care Med. 51(10) (2025) 1867–1885; https://doi.org/10.1007/s00134-025-08063-0
- Z. Wiley, J. T. Jacob and E. M. Burd, Targeting asymptomatic bacteriuria in antimicrobial steward-ship: The role of the microbiology laboratory, J. Clin. Microbiol. 58(5) (2020) e00518-18; https://doi.org/10.1128/JCM.00518-18
- H. Tien, K. Bond, W. Hong, K. Cronin and E. Chan, Exploring the association between the degree of pyuria and urinary tract infections, Microbiol. Spectr. 13(4) (2025) Article ID e0201524 (10 pages); https://doi.org/10.1128/spectrum.02015-24
- N. Shaikh, Ramifications of requiring pyuria for the diagnosis of urinary tract infection, Acta Paediatr. 113(12) (2024) 2502–2503; https://doi.org/10.1111/apa.17409
- M. Pulia, R. Redwood and L. May, Antimicrobial stewardship in the emergency department, Emerg. Med. Clin. North Am. 36(4) (2018) 853–872; https://doi.org/10.1016/j.emc.2018.06.012
- N. D. Stone, M. S. Ashraf, J. Calder, C. J. Crnich, K. Crossley, P. J. Drinka, C. V. Gould, M. Juthani-Mehta, E. Lautenbach, M. Loeb, T. Maccannell, P. N. Malani, L. Mody, J. M. Mylotte, L. E. Nicolle, M. C. Roghmann, S. J. Schweon, A. E. Simor, P. W. Smith, K. B. Stevenson, S. F. Bradley, and Society for Healthcare Epidemiology Long-Term Care Special Interest Group, Surveillance definitions of infections in long-term care facilities: Revisiting the McGeer criteria, Infect. Control Hosp. Epidemiol. 33(10) (2012) 965–977; https://doi.org/10.1086/667743
- B. Liu, H. Du, J. Zhang, J. Jiang, X. Zhang, F. He and B. Niu, Developing a new sepsis screening tool based on lymphocyte count, international normalized ratio and procalcitonin (LIP score), Sci. Rep. 12(1) (2022) Article 20002 (12 pages); https://doi.org/10.1038/s41598-022-16744-9
- L. Rodriguez-Manas, Urinary tract infections in the elderly: A review of disease characteristics and current treatment options, Drugs Context 9 (2020) Artcle ID 2020-4-13 (8 pages); https://doi.org/10.7573/dic.2020-4-13
- B. Foxman, Urinary tract infection syndromes: Occurrence, recurrence, bacteriology, risk factors, and disease burden, Infect. Dis. Clin. North Am. 28(1) (2014) 1–13; https://doi.org/10.1016/j.idc.2013.09.003
- T. Dahlberg, J. L. Baker, E. Bullitt and M. Andersson, Unveiling molecular interactions that stabilize bacterial adhesion pili, Biophys. J. 121(11) (2022) 2096–2106; https://doi.org/10.1016/j.bpj.2022.04.036
- B. K. Ackerson, S. Y. Tartof, L. H. Chen, R. Contreras, I. A. C. Reyes, J. H. Ku, M. Pellegrini, J. E. Schmidt and K. J. Bruxvoort, Risk factors for recurrent urinary tract infections among women in a large integrated health care organization in the United States, J. Infect. Dis. 230(5) (2024) e1101–e1111; https://doi.org/10.1093/infdis/jiae331
- N. Pakharukova, H. Malmi, M. Tuittila, T. Dahlberg, D. Ghosal, Y. W. Chang, S. L. Myint, S. Paavilainen, S. D. Knight, U. Lamminmäki, B. E. Uhlin, M. Andersson, G. Jensen and A. V. Zavialov, Archaic chaperone-usher pili self-secrete into superelastic zigzag springs, Nature 609(7926) (2022) 335–340; https://doi.org/10.1038/s41586-022-05095-0
- J. Böhning, A. W. Dobbelstein, N. Sulkowski, K. Eilers, A. von Kügelgen, A. K. Tarafder, S. Y. Peak-Chew, M. Skehel, V. Alva, A. Filloux and T. A. M. Bharat, Architecture of the biofilm-associated archaic chaperone-usher pilus CupE from Pseudomonas aeruginosa, PLoS Pathog. 19(4) (2023) Article ID e1011177 (20 pages); https://doi.org/10.1371/journal.ppat.1011177
- G. Schmiemann, J. Kranz, F. Mandraka, S. Schubert, F. Wagenlehner and I. Gágyor, The diagnosis, treatment, and prevention of recurrent urinary tract infection, Dtsch. Arztebl. Int. 121(11) (2024) 373–382; https://doi.org/10.3238/arztebl.m2024.0068
- J. Medina-Polo, K. G. Naber and T. E. Bjerklund Johansen, Healthcare-associated urinary tract infections in urology, GMS Infect. Dis. 9 (2021) Article ID Doc05 (13 pages); https://doi.org/10.3205/id000074
- O. Rahat, M. Shihab, E. Etedgi, D. Ben-David, I. Estrin, L. Goldshtein, S. Zilberman-Itskovich and D. Marchaim, Empiric usage of “anti-pseudomonal” agents for hospital-acquired urinary tract infections, Antibiotics (Basel) 11(7) (2022) Article ID 890 (13 pages); https://doi.org/10.3390/antibiotics11070890
- I. C. Schütt, G. E. Hansen, A. Koch-Pedersen, A. Lassen, F. S. Rosenvinge, C. Backer Mogensen, H. Skjøt-Arkil, L. Wulff Madsen and I. S. Johansen, Incidence and outcomes of patients admitted to emergency departments with urinary tract infections in Denmark: A retrospective cohort study, Ann. Med. 57(1) (2025) Article ID 890 2546059 (10 pages); https://doi.org/10.1080/07853890.2025.2546059
- A. Kawalec and D. Zwolinska, Emerging role of microbiome in the prevention of urinary tract infections in children, Int. J. Mol. Sci. 23(2) (2022) Article ID 870 (13 pages); https://doi.org/10.3390/ijms23020870
- Y. Zhou, Z. Zhou, L. Zheng, Z. Gong, Y. Li, Y. Jin, Y. Huang and M. Chi, Urinary tract infections caused by uropathogenic Escherichia coli: Mechanisms of infection and treatment options, Int. J. Mol. Sci. 24(13) (2023) Article ID 10537 (33 pages); https://doi.org/10.3390/ijms241310537
- L. Dudzik, P. Krzyzek and E. Dworniczek, A review on the current and future state of urinary tract infection diagnostics, Int. J. Mol. Sci. 26(22) (2025) Article ID 10847 (27 pages); https://doi.org/10.3390/ijms262210847
- S. Whelan, B. Lucey and K. Finn, Uropathogenic Escherichia coli (UPEC)-associated urinary tract infections: The molecular basis for challenges to effective treatment, Microorganisms 11(9) (2023) Article ID 2169 (32 pages); https://doi.org/10.3390/microorganisms11092169
- N. Boutouchent, T. N. A. Vu, L. Landraud and S. P. Kennedy, Urogenital colonization and pathogenicity of E. coli in the vaginal microbiota during pregnancy, Sci. Rep. 14(1) (2024) Article ID 25523 (16 pages); https://doi.org/10.1038/s41598-024-76438-2
- J. Geurtsen, M. de Been, E. Weerdenburg, A. Zomer, A. McNally and J. Poolman, Genomics and pathotypes of the many faces of Escherichia coli, FEMS Microbiol. Rev. 46(6) (2022) Article ID fuac031 (30 pages); https://doi.org/10.1093/femsre/fuac031
- B. Zalewska-Piatek, M. Nagorka and R. Piatek, Role of uropathogenic Escherichia coli and other pathogens in kidney stone formation: from pathogenesis to treatment, Pathogens 14(10) (2025) Article ID 991 (10 pages); https://doi.org/10.3390/pathogens14100991
- K. Eskandar, The role of uropathogenic Escherichia coli biofilms in antibiotic-resistant urinary tract infections: Nanoparticle-based, phage therapy, and quorum-sensing inhibitor approaches, Curr. Urol. 20(2) (2026) 82–88; https://doi.org/10.1097/CU9.0000000000000308
- A. Gatsios, C. S. Kim and J. M. Crawford, Escherichia coli small molecule metabolism at the host-microorganism interface, Nat. Chem. Biol. 17(10) (2021) 1016–1026; https://doi.org/10.1038/s41589-021-00807-5
- D. K. Govindarajan and K. Kandaswamy, Virulence factors of uropathogens and their role in host pathogen interactions, Cell Surf. 8 (2022) Article ID 100075 (12 pages); https://doi.org/10.1016/j.tcsw.2022.100075
- H. Zi, M.-Y. Liu, L.-S. Luo, Q. Huang, P.-C. Luo, H.-H. Luan, J. Huang, D.-Q. Wang, Y.-B. Wang, Y.-Y. Zhang, R.-P. Yu, Y.-T. Li, H. Zheng, T.-Z. Liu, Y. Fan and X.-T. Zeng, Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021, Mil. Med. Res. 11(1) (2024) Article ID 64 (18 pages); https://doi.org/10.1186/s40779-024-00569-w
- A. Flores and J. L. Rohn, Bacterial adhesion strategies and countermeasures in urinary tract infection, Nat. Microbiol. 10(3) (2025) 627–645; https://doi.org/10.1038/s41564-025-01926-8
- M. S. Conover, S. Ruer, J. Taganna, V. Kalas, H. De Greve, J. S. Pinkner, K. W. Dodson, H. Remaut and S. J. Hultgren, Inflammation-induced adhesin-receptor interaction provides a fitness advantage to uropathogenic E. coli during chronic infection, Cell Host Microbe 20(4) (2016) 482–492; https://doi.org/10.1016/j.chom.2016.08.013
- Vandana, M. Priyadarshanee and S. Das, Bacterial extracellular polymeric substances: Biosynthesis and interaction with environmental pollutants, Chemosphere 332 (2023) Article ID 138876 (2 pages); https://doi.org/10.1016/j.chemosphere.2023.138876
- H. Ragupathi, M. M. Pushparaj, S. M. Gopi, D. K. Govindarajan and K. Kandaswamy, Biofilm matrix: A multifaceted layer of biomolecules and a defensive barrier against antimicrobials, Arch. Microbiol. 206(11) (2024) Article ID 432 (2 pages); https://doi.org/10.1007/s00203-024-04157-3
- K. Sahoo and S. Meshram, Biofilm formation in chronic infections: A comprehensive review of pathogenesis, clinical implications, and novel therapeutic approaches, Cureus 16(10) (2024) Article ID e70629 (8 pages); https://doi.org/10.7759/cureus.70629
- E. Weerdenburg, S. King, J. Lubbers, E. Hovingh, T. Davies, J. Geurtsen, G. van den Dobbelsteen and J. Poolman, The bacterial Swiss army knife: ExPEC utilizes multiple resistance mechanisms to counteract host immune responses, Vaccines (Basel) 14(1) (2025) Article ID 51 (31 pages); https://doi.org/10.3390/vaccines14010051
- Y. Mulla and T. Bollenbach, Invade to evade: E. coli’s gutsy survival strategies, Cell Host Microbe 32(3) (2024) 300–301; https://doi.org/10.1016/j.chom.2024.02.006
- A. Zhao, J. Sun and Y. Liu, Understanding bacterial biofilms: From definition to treatment strategies, Front. Cell. Infect. Microbiol. 13 (2023) Article ID 1137947 (23 pages); https://doi.org/10.3389/fcimb.2023.1137947
- Y. Kwak, H. G. Kim, J. Seok, S. Kim, E. M. Kim and A. Kim, The critical role of intracellular bacterial communities in uncomplicated recurrent urinary cystitis: A comprehensive review of detection methods and diagnostic potential, Int. Neurourol. J. 28(1) (2024) 4–10; https://doi.org/10.5213/inj.2448066.033
- R. Kettlewell, C. Jones, T. W. Felton, M. Lagator and D. R. Gifford, Insights into durability against resistance from the antibiotic nitrofurantoin, npj Antimicrob. Resist. 2(1) (2024) 41 (6 pages); https://doi.org/10.1038/s44259-024-00056-1
- V. C. S. Scott, D. A. Haake, B. M. Churchill, S. S. Justice and J.-H. Kim, Intracellular bacterial communities: A potential etiology for chronic lower urinary tract symptoms, Urology 86(3) (2015) 425–431; https://doi.org/10.1016/j.urology.2015.04.002
- J. A. Munoz, A. C. Uhlemann and J. Barasch, Innate bacteriostatic mechanisms defend the urinary tract, Annu. Rev. Physiol. 84 (2022) 533–558; https://doi.org/10.1146/annurev-physiol-052521-121810
- T. Franza and D. Expert, Role of iron homeostasis in the virulence of phytopathogenic bacteria: An ‘à la carte’ menu, Mol. Plant Pathol. 14(4) (2013) 429–438; https://doi.org/10.1111/mpp.12007
- B. Khasheii, P. Mahmoodi and A. Mohammadzadeh, Siderophores: Importance in bacterial pathogenesis and applications in medicine and industry, Microbiol. Res. 250 (2021) Article ID 126790 (2 pages); https://doi.org/10.1016/j.micres.2021.126790
- M. Gallique, K. Wei, V. B. Maisuria, M. Okshevsky, G. McKay, D. Nguyen and N. Tufenkji, Cranberry-derived proanthocyanidins potentiate β-lactam antibiotics against resistant bacteria, Appl. Environ. Microbiol. 87(10) (2021) Article ID e00127-21 (15 pages); https://doi.org/10.1128/AEM.00127-21
- M. Khan, B. Zhang, H. Zhang, J. Wu, P. Gao and J. Li, Ureases in nature: Multifaceted roles and implications for plant and human health – a review, Int. J. Biol. Macromol. 306(3) (2025) Article ID 141702 (2 pages); https://doi.org/10.1016/j.ijbiomac.2025.141702
- B. N. V. Scott, T. Sarkar, R. M. Kratofil, P. Kubes and A. Thanabalasuriar, Unraveling the host’s immune response to infection: Seeing is believing, J. Leukoc. Biol. 106(2) (2019) 323–335; https://doi.org/10.1002/JLB.4RI1218-503R
- A. Horowitz and P. Heeger, Natural killer cells in kidney immune surveillance, injury and fibrosis, Nat. Rev. Nephrol. 22(3) (2026) 215–228; https://doi.org/10.1038/s41581-025-01029-x
- M. Al Qahtani, M. Naghib, A. M. M. Alshamrani, A. M. Al Mazroua, A. S. A. Alayyaf, S. B. Ofisan and S. M. Kamal, The incidence, clinical features and outcome of urinary tract infections in geriatric patients: A prospective longitudinal study, IJID Regions 13 (2024) Article ID 100469 (8 pages); https://doi.org/10.1016/j.ijregi.2024.100469
- A. Mari, M. Mahamid, H. Amara, F. A. Baker and A. Yaccob, Chronic constipation in the elderly patient: Updates in evaluation and management, Korean J. Fam. Med. 41(3) (2020) 139–145; https://doi.org/10.4082/kjfm.18.0182
- J. M. M. Barbosa, J. S. C. de Amorim, F. R. de Jesus Moraleida, V. T. M. Rocha, J. P. da Silva, B. Z. de Professor, D. C. Felicio, M. G. Assis and L. S. M. Pereira, Urinary symptoms in older people with low back pain: Prevalence, clinical, and functional factors associated, Neurourol. Urodyn. 40(8) (2021) 1999–2007; https://doi.org/10.1002/nau.24782
- T. Verma, G. S. Manhas and R. S. Manhas, Efficacy and safety of single-dose fosfomycin for un-complicated urinary tract infection in women: Systematic review and meta-analysis, J. Midlife Health 16(2) (2025) 124–136; https://doi.org/10.4103/jmh.jmh_77_24
- R. Hakimjavadi, C. Y. Yin, M. Scott, R. Talarico, T. Ramsay, C. Webber, D. Manuel, A. Moledina, A. T. Hsu, C. Fung, S. Kaasalainen, J. Kierulf, F. Molnar, S. Shamon, B. Robert, P. E. Ronksley, P. Tanuseputro, K. Wilson and D. Kobewka, Cognitive and functional decline among long-term care residents, JAMA Netw. Open 8(4) (2025) Article ID e255635 (12 pages); https://doi.org/10.1001/jamanetworkopen.2025.5635
- G. Arora, C. Milani, P. Tanuseputro, P. Tang, A. Jeong, D. Kobewka and C. Webber, Identifying predictors of cognitive decline in long-term care: A scoping review, BMC Geriatr. 23(1) (2023) Article ID 538 (9 pages); https://doi.org/10.1186/s12877-023-04193-6
- S. Mayne, A. Bowden, P. D. Sundvall and R. Gunnarsson, The scientific evidence for a potential link between confusion and urinary tract infection in the elderly is still confusing – a systematic literature review, BMC Geriatr. 19(1) (2019) Article ID 32 (15 pages); https://doi.org/10.1186/s12877-019-1049-7
- N. D. Stone, M. S. Ashraf, J. Calder, C. J. Crnich, K. Crossley, P. J. Drinka, C. V. Gould, M. Juthani-Mehta, E. Lautenbach, M. Loeb, T. Maccannell, P. N. Malani, L. Mody, J. M. Mylotte, L. E. Nicolle, M. C. Roghmann, S. J. Schweon, A. E. Simor, P. W. Smith, K. B. Stevenson and S. F. Bradley, Surveillance definitions of infections in long-term care facilities: Revisiting the McGeer criteria, Infect. Control Hosp. Epidemiol. 33(10) (2012) 965–977; https://doi.org/10.1086/667743
- K. Kuroda, A. N. Nizinski, K. Kyi, S. K. Ayo, E. Kirkpatrick, I. M. Deutchki and D. L. Nelson, Patterns of urine testing and antibiotic use for atypical UTI symptoms in cognitively impaired long-term care residents: A retrospective study of diagnostic criteria adherence, Cureus 17(8) (2025) Article ID e90422 (10 pages); https://doi.org/10.7759/cureus.90422
- N. Theodorakis, G. Feretzakis, C. Hitas, M. Kreouzi, S. Kalantzi, A. Spyridaki, Z. Kollia, V. S. Verykios and M. Nikolaou, Immunosenescence: How aging increases susceptibility to bacterial infections and virulence factors, Microorganisms 12(10) (2024) Article ID 2052 (18 pages); https://doi.org/10.3390/microorganisms12102052
- Y. Yang, C. Li, X. Fan, W. Long, Y. Hu, Y. Wang and J. Qu, Effectiveness of omadacycline in a patient with Chlamydia psittaci and KPC-producing gram-negative bacteria infection, Infect Drug Resist. 18 (2025) 903–908. https://doi.org/10.2147/IDR.S505311
- H.-H. Zhuang, Q. Qu, W.-M. Long, Q. Hu, X.-L. Wu, Y. Chen, Q. Wan, T.-T. Xu, Y. Luo, H.-Y. Yuan, Q. Lu and J. Qu, Ceftazidime/avibactam versus polymyxin B in carbapenem-resistant Klebsiella pneumoniae infections: A propensity score-matched multicenter real-world study, Infection 53(1) (2025) 95–106; https://doi.org/10.1007/s15010-024-02324-8
- H.-H. Zhuang, Y. Chen, Q. Hu, W.-M. Long, X.-L. Wu, Q. Wang, T.-T. Xu, Q. Qu, Y.-P. Liu, Y.-W. Xiao and J. Qu, Efficacy and mortality of ceftazidime/avibactam-based regimens in carbapenem--resistant Gram-negative bacteria infections: A retrospective multicenter observational study, J. Infect. Public Health 16(6) (2023) 938–947. https://doi.org/10.1016/j.jiph.2023.04.014
- A. M. Sandu, M. C. Chifiriuc, C. O. Vrancianu, R. E. Cristian, C. F. Alistar, M. Constantin, M. Paun, A. Alistar, L. G. Popa, M. I. Popa, A. C. Tantu, M. E. Sidoroff, M. M. Mihai, A. Marcu, G. Popescu and M. M. Tantu, Healthcare-associated infections: The role of microbial and environmental factors in infection control – a narrative review, Infect. Dis. Ther. 14(5) (2025) 933–971; https://doi.org/10.1007/s40121-025-01143-0
- A. Giarratano, S. E. Green and D. P. Nicolau, Review of antimicrobial use and considerations in the elderly population, Clin. Interv. Aging 13 (2018) 657–667; https://doi.org/10.2147/CIA.S133640
- L. Soraci, A. Cherubini, L. Paoletti, G. Filippelli, F. Luciani, P. Lagana, M. E. Gambuzza, E. Filicetti, A. Corsonello and F. Lattanzio, Safety and tolerability of antimicrobial agents in the older patient, Drugs Aging 40(6) (2023) 499–526; https://doi.org/10.1007/s40266-023-01019-3
- L. Grigoryan, R. Zoorob, H. Wang and B. W. Trautner, Low concordance with guidelines for treatment of acute cystitis in primary care, Open Forum Infect. Dis. 2(4) (2015) Article ID ofv159 (6 pages); https://doi.org/10.1093/ofid/ofv159
- K. Gupta, T. M. Hooton, P. L. Roberts and W. E. Stamm, Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women, Arch. Intern. Med. 167(20) (2007) 2207–2212; https://doi.org/10.1001/archinte.167.20.2207
- D. Wong and T. Perry, Oral versus intravenous antibiotics: Oral antibiotics are more cost-effective and may be safer than intravenous antibiotics for most infections in stable adults, Afr. J. Prim. Health Care Fam. Med. 17(1) (2025) e1–e5; https://doi.org/10.4102/phcfm.v17i1.5282
- G. Mancuso, A. Midiri, E. Gerace, M. Marra, S. Zummo and C. Biondo, Urinary tract infections: The current scenario and future prospects, Pathogens 12(4) (2023) Article ID 623 (17 pages); https://doi.org/10.3390/pathogens12040623
- A.-X. Shi, Q. Qu, H.-H. Zhuang, X.-Q. Teng, W.-X. Xu, Y.-P. Liu, Y. W. Xiao and J. Qu, Individualized antibiotic dosage regimens for patients with augmented renal clearance, Front Pharmacol. 14 (2023) Article ID 1137975 (14 pages); https://doi.org/10.3389/fphar.2023.1137975
- H. Moore, D. Yeoh, C. Hughes, E. Raby and I. Sandaradura, Aminoglycosides: An update on indications, dosing and monitoring, Aust. Prescr. 48(4) (2025) 133–138; https://doi.org/10.18773/austprescr.2025.038
- M. Mahdizade Ari, S. Dashtbin, F. Ghasemi, S. Shahroodian, P. Kiani, E. Bafandeh, T. Darbandi, R. Ghanavati and A. Darbandi, Nitrofurantoin: Properties and potential in treatment of urinary tract infection – a narrative review, Front. Cell. Infect. Microbiol. 13 (2023) Article ID 1148603 (13 pages); https://doi.org/10.3389/fcimb.2023.1148603
- L. Wang, H. Qiu, X. Tan, J.-J. Liu, T. Yang and C. Jiang, Impact of roxadustat on anemia management in infected patients undergoing long-term dialysis: A retrospective cohort analysis, Front. Pharmacol. 16 (2025) Article ID (1695376) (10 pages). https://doi.org/10.3389/fphar.2025.1695376
- T. Ten Doesschate, R. H. H. Groenwold, M. J. M. Bonten and C. H. van Werkhoven, Effectiveness of extended-versus normal-release nitrofurantoin for cystitis: An instrumental variable analysis, J. Antimicrob. Chemother. 74(11) (2019) 3337–3343; https://doi.org/10.1093/jac/dkz350
- Y.-K. Li, W.-R. Li, H. Ren, C.-L. Xiao, Z. Guo and J.-Q. Luo, Gut microbiome-targeted therapeutics for chronic kidney disease: Comparative efficacy of probiotic and microbial preparations, Inflammopharmacology 33(12) (2025) 7569–7585; https://doi.org/10.1007/s10787-025-02044-x
- B. J. Gardiner, A. J. Stewardson, I. J. Abbott and A. Y. Peleg, Nitrofurantoin and fosfomycin for resistant urinary tract infections: Old drugs for emerging problems, Aust. Prescr. 42(1) (2019) 14–19; https://doi.org/10.18773/austprescr.2019.002
- M. Laws, A. Shaaban and K. M. Rahman, Antibiotic resistance breakers: Current approaches and future directions, FEMS Microbiol. Rev. 43(5) (2019) 490–516; https://doi.org/10.1093/femsre/fuz014
- S. Xu, Z. Song, F. Han and C. Zhang, Effect of appropriate empirical antimicrobial therapy on mortality of patients with Gram-negative bloodstream infections: A retrospective cohort study, BMC Infect. Dis. 23(1) (2023) Article ID 344 (8 pages); https://doi.org/10.1186/s12879-023-08329-2
- M. Gharbi, J. H. Drysdale, H. Lishman, R. Goudie, M. Molokhia, A. P. Johnson, A. H. Holmes and P. Aylin, Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all-cause mortality: Population-based cohort study, BMJ 364 (2019) Article ID l525 (12 pages); https://doi.org/10.1136/bmj.l525
- Eurosurveillance editorial team, ECDC publishes 2014 surveillance data on antimicrobial resistance and antimicrobial consumption in Europe, Euro Surveill. 20(46) (2015) 39–39; https://doi.org/10.2807/1560-7917.ES.2015.20.46.30068
- V. Rico-Caballero, M. Romero-Rivera, A. Moreno-Blanco, A. Aira, C. Casals-Pascual, C. Rodríguez-Jiménez, C. Quereda, A. Soriano and R. Del Campo, Fecal microbiota transplant as treatment for recurrent urinary tract infections: A proof-of-concept study, Eur. J. Clin. Microbiol. Infect. Dis. 44(10) (2025) 2549–2554; https://doi.org/10.1007/s10096-025-05202-9
- F. J. New, S. Theivendrampillai, P. Juliebø-Jones and B. Somani, Correction to: Role of probiotics for recurrent UTIs in the twenty-first century: A systematic review of literature, Curr. Urol. Rep. 25(9) (2024) Article ID 241 (1 page); https://doi.org/10.1007/s11934-022-01105-w
- F. Montorsi, G. Gandaglia, A. Salonia, A. Briganti and V. Mirone, Effectiveness of a combination of cranberries, Lactobacillus rhamnosus, and vitamin C for the management of recurrent urinary tract infections in women: Results of a pilot study, Eur. Urol. 70(6) (2016) 912–915; https://doi.org/10.1016/j.eururo.2016.05.042
- Z. Zhou, H. Fu, M. Li, Z. Han, Z. Wu, H. Fan, N. Shen and J. Zheng, Bacteriophage therapy: Current strategies and future perspectives, MedComm. 7(3) (2026) Article ID e70645 (33 pages); https://doi.org/10.1002/mco2.70645
- T. Cai and R. Bartoletti, Asymptomatic bacteriuria in recurrent UTI – to treat or not to treat, GMS Infect Dis. 5 (2017) Article ID Doc09 (4 pages); https://doi.org/10.3205/id000035
- M. A. Syed, U. Manzoor, I. Shah and S. H. Bukhari, Antibacterial effects of tungsten nanoparticles on Escherichia coli strains isolated from catheterized urinary tract infection cases and Staphylococcus aureus, New Microbiol. 33(4) (2010) 329–335.
- D. R. Hickling and V. W. Nitti, Management of recurrent urinary tract infections in healthy adult women, Rev. Urol. 15(2) (2013) 41–48.
- S. Wang, C. Yang and L. Chen, LSA-DDI: Learning stereochemistry-aware drug interactions via 3D feature fusion and contrastive cross-attention, Int. J. Mol. Sci. 26(14) (2025) Article ID (6799) (17 pages); https://doi.org/10.3390/ijms26146799
- T. Skuhala, M. Rimac, V. Trkulja and S. Zidovec-Lepej, Antimicrobial prophylaxis for recurrent urinary tract infections in premenopausal and postmenopausal women: A retrospective observational study from an outpatient clinic in a tertiary university hospital, Antibiotics (Basel) 14(10) (2025) Article ID (21 pages); https://doi.org/10.3390/antibiotics14100998
- P. Jent, J. Berger, A. Kuhn, B. W. Trautner, A. Atkinson and J. Marschall, Antibiotics for preventing recurrent urinary tract infection: Systematic review and meta-analysis, Open Forum Infect. Dis. 9(7) (2022) Article ID ofac327 (8 pages); https://doi.org/10.1093/ofid/ofac327
- H. Harrabi, C. Mamona-Kilu, E. Meyer, E. d’Anglejan Chatillon, N. Dournon, F. Bouchand, C. Duran, V. Perronne, K. Jaffal and A. Dinh, Treatment duration in bacterial prosthetic joint infections: A narrative review of current evidence, Antibiotics (Basel) 14(11) (2025) Article ID 1066 (20 pages); https://doi.org/10.3390/antibiotics14111066
- V. T. Guinto, B. De Guia, M. R. Festin and T. Dowswell, Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy, Cochrane Database Syst. Rev. 2010(9) (2010) Article ID CD007855 (33 pages); https://doi.org/10.1002/14651858.CD007855.pub2
- J. Kranz, S. Schmidt, C. Lebert, L. Schneidewind, G. Schmiemann and F. Wagenlehner, Uncomplicated bacterial community-acquired urinary tract infection in adults, Dtsch. Arztebl. Int. 114(50) (2017) 866–873; https://doi.org/10.3238/arztebl.2017.0866
- D. H. Zhou and Q. G. Zhang, Fast drug rotation reduces bacterial resistance evolution in a microcosm experiment, J. Evol. Biol. 36(4) (2023) 641–649; https://doi.org/10.1111/jeb.14163
- P. A. Bergamin and A. J. Kiosoglous, Non-surgical management of recurrent urinary tract infections in women, Transl. Androl. Urol. 6(2) (2017) S142–S152; https://doi.org/10.21037/tau.2017.06.09
- J. Y. Xia, C. Yang, D. F. Xu, H. Xia, L. G. Yang and G. J. Sun, Consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: A systematic review and meta-analysis with trial sequential analysis, PLoS One 16(9) (2021) Article ID e0256992 (17 pages); https://doi.org/10.1371/journal.pone.0256992
- Y. Y. Chen, T. H. Su and H. H. Lau, Estrogen for the prevention of recurrent urinary tract infections in postmenopausal women: A meta-analysis of randomized controlled trials, Int. Urogynecol. J. 32(1) (2021) 17–25; https://doi.org/10.1007/s00192-020-04397-z
- B. Eriksen, A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women, Am. J. Obstet. Gynecol. 180(5) (1999) 1072–1079; https://doi.org/10.1016/S0002-9378(99)70597-1
- T. E. Cooper, C. Teng, M. Howell, A. Teixeira-Pinto, A. Jaure and G. Wong, d-mannose for preventing and treating urinary tract infections, Cochrane Database Syst. Rev. 8(8) (2022) Article ID CD013608 (59 pages); https://doi.org/10.1002/14651858.CD013608.pub2
- F. Wagenlehner, H. Lorenz, O. Ewald and P. Gerke, Why D-mannose may be as efficient as antibiotics in the treatment of acute uncomplicated lower urinary tract infections – preliminary considerations and conclusions from a non-interventional study, Antibiotics (Basel) 11(3) (2022) Article ID 314 (12 pages); https://doi.org/10.3390/antibiotics11030314
- B. C. Porto, A. S. Almeida, B. D. Terada, F. G. Gonçalves, C. C. Passerotti, R. A. Sardenberg, J. P. Otoch and J. A. Cruz, Uro-Vaxom (OM-89) for chronic UTI prevention: An updated meta-analysis, meta-regression and trial sequential analysis of recent clinical evidence, Minerva Urol. Nephrol. 77(5) (2025) 618–628; https://doi.org/10.23736/S2724-6051.25.06366-9
- C. Sze, S. Attia and P. Zimmern, Effective risk reduction strategies and pharmacological treatment for uncomplicated recurrent urinary tract infections, Expert Opin. Pharmacother. 26(16) (2025) 1699–1711; https://doi.org/10.1080/14656566.2025.2584405
- M.-F. Lorenzo-Gómez, S. Foley, J. C. Nickel, M.-B. García-Cenador, B. Y. Padilla-Fernández, I. González-Casado, M. Martínez-Huélamo, B. Yang, C. Blick, F. Ferreira, R. Caballero, P. Saz-Leal and M. Casanovas, Sublingual MV140 for prevention of recurrent urinary tract infections, NEJM Evid. 1(4) (2022) Article ID EVIDoa2100018 (11 pages); https://doi.org/10.1056/EVIDoa2100018
- S. Nestler, B. Grüne, L. Schilchegger, A. Suna, A. Perez and A. Neisius, Efficacy of vaccination with StroVac for recurrent urinary tract infections in women: A comparative single-centre study, Int. Urol. Nephrol. 53(11) (2021) 2267–2272; https://doi.org/10.1007/s11255-021-02987-4
- A. Cicione, F. Cantiello, G. Ucciero, A. Salonia, M. Torella, M. De Sio, R. Autorino, A. Carbone, M. Romancik, R. Tomaskin and R. Damiano, Intravesical treatment with highly concentrated hyaluronic acid and chondroitin sulphate in patients with recurrent urinary tract infections: Results from a multicentre survey, Can. Urol. Assoc. J. 8(9-10) (2014) E721–E727; https://doi.org/10.5489/cuaj.1989
- N. C. Hobaica, G. C. De Oliveira, B. C. Porto, C. C. Passerotti, R. A. da Silva Sardenberg, J. P. Otoch and J. A. S. da Cruz, Effectiveness of methenamine hippurate in preventing urinary tract infections: An updated systematic review, meta-analysis and trial sequential analysis of randomized controlled trials, BMC Urol. 25(1) (2025) Article ID 30 (10 pages); https://doi.org/10.1186/s12894-025-01708-8
- J. C. Goddard and D. A. W. Janssen, Intravesical hyaluronic acid and chondroitin sulfate for recurrent urinary tract infections: Systematic review and meta-analysis, Int. Urogynecol. J. 29(7) (2018) 933–942; https://doi.org/10.1007/s00192-017-3508-z
Language: English
Page range: 1 - 25
Accepted on: May 29, 2026
Published on: Jun 30, 2026
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:
© 2026 Junmei Lv, Ajaz Ahmad Waza, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.